Covid-19 Research

Research Article

Clinical Appearance and Diagnosis of Heparin Induced Thrombocytopenia

Journal of Biomedical Research & Environmental Sciences article abstract with citation details, DOI, publication dates, subject areas, full text links, and references.

View DOI Submit Manuscript

Article Details

Publication record, authors, dates, abstract, and full text access.

Open Access
Article Type Research Article
Subject Medicine Group
OCLC 9124865572
Tayfun Gunduz*, Murat Cakir, Eftal Murat Bakirci and Husnu DEGIRMENCI
Issue: Volume2-Issue6
Pages: 466-471
Received: 2021-05-17
Accepted: 2021-06-07
Published: 2021-06-08

Abstract

Heparin-Ä°nduced Thrombocytopenia (HIT) is a life-threatening complication that occurs in a small percentage of exposed patients (e.g. unfractionated heparin, Low Molecular Weight Heparin [LMWH]) regardless of dose and treatment management.

FullText HTML FullText PDF DOI: 10.37871/jbres1262 Crossmark

Certificate of Publication

Certificate of Publication

Copyright

© 2021 Gunduz T, et al.. Distributed under Creative Commons CC-BY 4.0 Creative CommonsAttribution

How to cite this article

Gunduz T, Cakir M, Bakirci EM, DEGIRMENCI H. Clinical Appearance and Diagnosis of Heparin Induced Thrombocytopenia. J Biomed Res Environ Sci. 2021 June 08; 2(6): 466-471. doi: 10.37871/jbres1262, Article ID: jbres1262

Subject area(s)

Blood DisordersClinical Cardiology

References

  1. Arepally GM. Heparin-induced thrombocytopenia. Blood. 2017 May 25;129(21):2864-2872. doi: 10.1182/blood-2016-11-709873. Epub 2017 Apr 17. PMID: 28416511; PMCID: PMC5445568.
  2. Cuker A, Arepally GM, Chong BH, Cines DB, Greinacher A, Gruel Y, Linkins LA, Rodner SB, Selleng S, Warkentin TE, Wex A, Mustafa RA, Morgan RL, Santesso N. American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia. Blood Adv. 2018 Nov 27;2(22):3360-3392. doi: 10.1182/bloodadvances.2018024489. PMID: 30482768; PMCID: PMC6258919.
  3. Cuker A. Management of the multiple phases of heparin-induced thrombocytopenia. Thromb Haemost. 2016 Oct 28;116(5):835-842. doi: 10.1160/TH16-02-0084. Epub 2016 Apr 14. PMID: 27075525.
  4. Greinacher A, Selleng K, Warkentin TE. Autoimmune heparin-induced thrombocytopenia. J Thromb Haemost. 2017 Nov;15(11):2099-2114. doi: 10.1111/jth.13813. Epub 2017 Sep 28. PMID: 28846826.
  5. Warkentin TE, Kelton JG. Delayed-onset heparin-induced thrombocytopenia and thrombosis. Ann Intern Med. 2001 Oct 2;135(7):502-6. doi: 10.7326/0003-4819-135-7-200110020-00009. PMID: 11578153.
  6. Warkentin TE, Basciano PA, Knopman J, Bernstein RA. Spontaneous heparin-induced thrombocytopenia syndrome: 2 new cases and a proposal for defining this disorder. Blood. 2014 Jun 5;123(23):3651-4. doi: 10.1182/blood-2014-01-549741. Epub 2014 Mar 27. PMID: 24677540.
  7. Ahmed I, Majeed A, Powell R. Heparin induced thrombocytopenia: diagnosis and management update. Postgrad Med J. 2007 Sep;83(983):575-82. doi: 10.1136/pgmj.2007.059188. PMID: 17823223; PMCID: PMC2600013.
  8. Christoffersen C, Lethagen S, Gøtze JP. Heparininduceret trombocytopeni [Heparin-induced thrombocytopenia]. Ugeskr Laeger. 2009 Feb 16;171(8):612-5. Danish. PMID: 19284907.
  9. Chong BH, Isaacs A. Heparin-induced thrombocytopenia: what clinicians need to know. Thromb Haemost. 2009 Feb;101(2):279-83. PMID: 19190810.
  10. Perdomo J, Leung HHL, Ahmadi Z, Yan F, Chong JJH, Passam FH, Chong BH. Neutrophil activation and NETosis are the major drivers of thrombosis in heparin-induced thrombocytopenia. Nat Commun. 2019 Mar 21;10(1):1322. doi: 10.1038/s41467-019-09160-7. PMID: 30899022; PMCID: PMC6428879.
Publish with JBRES — Peer-reviewed, multidisciplinary Open Access with rapid review, DOI, and global visibility.
Double-Blind CrossRef DOI Discoverable
Submit Manuscript Membership